| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_641e9039b4b8a3c02bb224e5a3da4e9b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-11-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a654596e8e7c1c5b6081d4d81840cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_927b0ea050337dbf3ede0add4cb5401b |
| publicationDate |
2002-06-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10058847-A1 |
| titleOfInvention |
Method for identifying patients with chronic myeloid leukemia (CML) susceptible to interferon therapy |
| abstract |
The invention relates to a method for identifying a patient with chronic myeloid leukemia (CML) susceptible to interferon therapy, the patients concerned being selected by determining an interferon regulatory factor (IRF). Furthermore, the invention relates to an associated diagnostic method and an agent for gene therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1417297-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1417297-A4 |
| priorityDate |
2000-11-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |